| Nov 18, 2024 (view filing)9:12 PM ET | Nov 14 | 4 days | BB Biotech AG and 1 other10% Owner | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase. | −1.28M | $0.6609 | −$845.8K | −100.0%0 after | |
| Nov 18, 2024 (view filing)9:12 PM ET | Apr 2 | 230 daysLateFiled more than 2 business days after the trade (the Form 4 deadline). A few cases, such as trades a broker makes under a 10b5-1 plan, have a longer deadline, so this flag comes from the dates alone and does not mean a rule was broken. | BB Biotech AG and 1 other10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +904.0K | $0.4563 | +$412.5K | –769.3K after | DerivativeA trade in a derivative security (option, warrant, restricted stock unit and so on). The value is the derivative's own price times the quantity.2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average.Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Apr 4, 2024 (view filing)8:13 PM ET | Apr 2 | 2 days | BB Biotech AG and 1 other10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +250.0K | $2.35 | +$587.5K | +24.3%1.28M after | |
| Apr 4, 2024 (view filing)8:13 PM ET | Apr 2 | 2 days | BB Biotech AG and 1 other10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +904.0K | $0.4563 | +$412.5K | –769.3K after | DerivativeA trade in a derivative security (option, warrant, restricted stock unit and so on). The value is the derivative's own price times the quantity.2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average. |
| Jul 19, 2023 (view filing)3:14 PM ET | Jul 17 | 2 days | BB Biotech AG and 1 other10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +4.26M | $0.47 | +$2.00M | +38.0%15.4M after | |
| Jun 21, 2022 (view filing)5:09 PM ET | Jun 13-15 | 8 daysLateFiled more than 2 business days after the trade (the Form 4 deadline). A few cases, such as trades a broker makes under a 10b5-1 plan, have a longer deadline, so this flag comes from the dates alone and does not mean a rule was broken. | French Douglas D and 6 others10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +222.0K | $0.8936 | +$198.4K | New position222.0K after | 3 lotsThis row combines 3 trades of the same kind from one filing. The price is the value-weighted average.Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Jun 21, 2022 (view filing) | Jun 13-15 | 8 daysLateFiled more than 2 business days after the trade (the Form 4 deadline). A few cases, such as trades a broker makes under a 10b5-1 plan, have a longer deadline, so this flag comes from the dates alone and does not mean a rule was broken. | Lalande Kevin M.Director, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +222.0K | $0.8936 | +$198.4K | New position222.0K after | 3 lotsThis row combines 3 trades of the same kind from one filing. The price is the value-weighted average. |
| Jun 21, 2022 (view filing) | Jun 16 | 5 days | McLennan SeanSee remarks | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +30.0K | $0.82 | +$24.6K | New position30.0K after | |
| May 18, 2022 (view filing)12:21 PM ET | May 16 | 2 days | BB Biotech AG and 1 other10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +200.0K | $1.18 | +$236.2K | +1.8%11.2M after | |
| Jan 10, 2022 (view filing)11:49 AM ET | Jan 6 | 4 days | BB Biotech AG and 1 other10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +200.0K | $4.04 | +$807.2K | +1.9%11.0M after | |
